‘Unconscionable’: Pfizer, Moderna to Rake in Combined $93 Billion in 2022 COVID Vaccine Sales

A report by health data analytics group, Airfinity, projects “unprecedented” sales and profits for Pfizer and Moderna in 2022. According to the People’s Vaccine Alliance, the companies are pricing their vaccines by as much as $41 billion above the estimated cost of production.